Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
Perrigo (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced that CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will present at the virtual Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference on June 10 at 9 AM ET.
Perrigo is a pure-play self-care company operating primarily in North America and Europe, specializing in over-the-counter (OTC) healthcare products. The company's business model combines store brand private label offerings with branded products including OpillĀ®, MedermaĀ®, CompeedĀ®, EllaOneĀ®, and SolpadeineĀ®.
Perrigo (NYSE: PRGO), un importante fornitore di prodotti per l'autocura dei consumatori, ha annunciato che il CEO Patrick Lockwood-Taylor e il CFO Eduardo Bezerra parteciperanno alla conferenza virtuale Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference il 10 giugno alle 9:00 ET.
Perrigo ĆØ un'azienda specializzata esclusivamente nell'autocura, operante principalmente in Nord America ed Europa, con un focus sui prodotti sanitari da banco (OTC). Il modello di business dell'azienda combina offerte di marchi privati con prodotti di marca, tra cui OpillĀ®, MedermaĀ®, CompeedĀ®, EllaOneĀ® e SolpadeineĀ®.
Perrigo (NYSE: PRGO), un proveedor lĆder de productos de autocuidado para el consumidor, anunció que el CEO Patrick Lockwood-Taylor y el CFO Eduardo Bezerra presentarĆ”n en la conferencia virtual Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference el 10 de junio a las 9 AM ET.
Perrigo es una empresa especializada exclusivamente en autocuidado, que opera principalmente en NorteamĆ©rica y Europa, y se especializa en productos de venta libre (OTC). El modelo de negocio de la compaƱĆa combina ofertas de marca privada con productos de marca reconocida, incluyendo OpillĀ®, MedermaĀ®, CompeedĀ®, EllaOneĀ® y SolpadeineĀ®.
Perrigo (NYSE: PRGO)ė� ģė¹ģ� ģź° ź“ė¦� ģ ķģ� ģ ė ģ ź³µģ 첓ė”ģ, CEO Patrick Lockwood-Taylorģ CFO Eduardo Bezerraź° 6ģ� 10ģ� ģ¤ģ 9ģ�(ėė¶ģź°)ģ� ģ“리ė� ź°ģ� Oppenheimer 25th Annual Consumer Growth & E-Commerce Conferenceģģ ė°ķķ� ģģ ģģ ė°ķķģµėė¤.
Perrigoė� ģ£¼ė” ė¶ėÆøģ ģ ė½ģģ ģ“ģėė ģģ ģź° ź“ė¦� źø°ģ ģ¼ė”, ģ¼ė°ģģ½ķ�(OTC) ź±“ź°ź“ė¦� ģ ķģ� ģ 문ģ¼ė” ķ©ėė�. ķģ¬ģ� ė¹ģ¦ėģ¤ ėŖØėøģ ģ첓 ģķ(private label) ģ ķź³� OpillĀ®, MedermaĀ®, CompeedĀ®, EllaOneĀ®, SolpadeineĀ®ģ ź°ģ ėøėė� ģ ķģ� ź²°ķ©ķ©ėė�.
Perrigo (NYSE : PRGO), un fournisseur leader de produits d'autosoins pour les consommateurs, a annoncé que le PDG Patrick Lockwood-Taylor et le directeur financier Eduardo Bezerra présenteront lors de la conférence virtuelle Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference le 10 juin à 9h00 ET.
Perrigo est une entreprise spécialisée exclusivement dans l'autosoins, opérant principalement en Amérique du Nord et en Europe, spécialisée dans les produits de santé en vente libre (OTC). Le modèle commercial de l'entreprise combine des offres de marques de distributeur avec des produits de marque tels que Opill®, Mederma®, Compeed®, EllaOne® et Solpadeine®.
Perrigo (NYSE: PRGO), ein führender Anbieter von Consumer Self-Care-Produkten, gab bekannt, dass CEO Patrick Lockwood-Taylor und CFO Eduardo Bezerra auf der virtuellen Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference am 10. Juni um 9 Uhr ET präsentieren werden.
Perrigo ist ein reines Self-Care-Unternehmen, das hauptsächlich in Nordamerika und Europa tätig ist und sich auf rezeptfreie (OTC) Gesundheitsprodukte spezialisiert hat. Das Geschäftsmodell des Unternehmens kombiniert Eigenmarkenangebote mit Markenprodukten wie Opill®, Mederma®, Compeed®, EllaOne® und Solpadeine®.
- None.
- None.
Interested parties can access the webcast on the Perrigo website atĀ http://perrigo.investorroom.com/events-webcasts.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including OpillĀ®, MedermaĀ®, CompeedĀ®, EllaOneĀ®, and SolpadeineĀ®.
For more information, visit .
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's presentation at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995', as amended. Forward-looking statements relate to future events and involve known and unknown risks, uncertainties and other factorsāmany of which beyond the Company's controlāthat may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at , for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.
Perrigo Investor Contact
Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications; (269) 686-3373; e-mail: [email protected]
Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications; (269) 686-3238, e-mail: [email protected]
View original content to download multimedia:
SOURCE Perrigo Company plc